It is not known if BENLYSTA causes these serious side effects. - Heart problems: chest discomfort or pain, shortness of breath, cold sweats, nausea, dizziness, or discomfort in other areas of the upper body. Difference between primaquine and chloroquine Plaquenil rash side effect Chloroquine brand name in pakistan Hydroxychloroquine dangers With Plaquenil, however, the most commonly prescribed anti-malarial, this sort of damage occurs only in 1 out of 5,000 people who take the drug for five years or more. For this reason though, it is important that you see an ophthalmologist for an exam before starting to take an anti-malarial medication for your lupus. Mar 09, 2011 March 9, 2011 -- The FDA has approved Benlysta, the first new lupus treatment in 50 years. An FDA advisory panel last November voted 13-2 in favor of approval. But the panel noted that Benlysta is no wonder drug. Overall, it offered a modest benefit. Only 30% of patients who took the drug in clinical trials. May 18, 2018 While Benlysta is the first new lupus drug to be approved by the FDA in over fifty years, we know it just doesn’t work for everyone. In my own treatment history over the past twenty-five years, I have taken plaquenil, sulindac, prednisone, methotrexate, azathioprine, rituximab and Benlysta to treat and control my lupus activity and symptoms. Serious allergic reactions can happen on the day of, or in the days after, receiving BENLYSTA and may cause death. - Allergic (hypersensitivity) reactions: itching, swelling of the face, lips, mouth, tongue, or throat, trouble breathing, anxiousness, low blood pressure, dizziness or fainting, headache, nausea, or skin rash. Benlysta and plaquenil Compare Benlysta vs Plaquenil - Comprehensive, New Lupus Treatment Benlysta Approved FAQ on Safety. Clinical pearls hydroxychloroquineIs 200 milligrams of hydroxychloroquine high Clinical trials are an incredibly important contribution to new drugs for lupus. Before 2011, there had not been any new FDA approved drugs for systemic lupus in over 50 years. Before that there were only three, aspirin, plaquenil and prednisone. Now, with Benlysta, there are four. Benlysta for Lupus Without Infusions? Lupus, the Adventure.. Benlysta Journal Lupus, the Adventure Between the Lines. Lupus & Medications An HSS Facebook Chat - HSS.edu. BENLYSTA is a human monoclonal antibody that was approved for the treatment of lupus by the U. S. Food and Drug Administration FDA on March 9, 2011. A monoclonal antibody is a type of protein made in the laboratory that is developed to find and attach to only one type of substance in the body. Benlysta is a pain relief medication. Plaquenil is an arthritis medication and an anti infectious agent. There may be a negative interaction between Benlysta and alcohol. There may be a negative interaction between Plaquenil and alcohol. What is BENLYSTA? BENLYSTA is a prescription medicine for patients with active systemic lupus erythematosus SLE or lupus receiving other lupus medicines. Intravenous dosing of BENLYSTA is approved for patients 5 years and older, and subcutaneous dosing is only approved for adults.